Your search for ‘Bass, Berry & Sims’ returned 818 results

A federal district court in Florida recently ruled that the False Claim Act's qui tam provision—which allows private citizens to file suit on behalf of the federal government—is unconstitutional and thus unenforceable.

In the First Session of the 113th General Assembly, Tennessee legislators sponsored numerous bills that impacted local governments in some measure. Due to this uptick...

The 113th General Assembly adjourned its first of two annual regular sessions on April 21, 2023, approximately one month after the Covenant School shooting.

Bass, Berry & Sims hosted the 15th annual Health Care Investors Conference (HCIC), co-sponsored by Deloitte, Gallagher and Houlihan Lokey, on October 29.

In the current business environment, companies must have a documented plan for responding to government investigations.

Law firms nationwide are incorporating wellbeing and mental wellness programs and initiatives into their business strategy.

On December 13, 2022, the Securities and Exchange Commission (SEC) issued seven new or revised Compliance and Disclosure Interpretations (C&DIs) on topics regarding the use of non-GAAP...

The Starbucks settlement shows that state attorneys general are also scrutinizing employment and corporate governance practices involving race- or sex-based goals, preferences, and participation requirements.

On August 28, as part of its Fiscal Year 2025 Hospital Inpatient Prospective Payment System (IPPS) Final Rule, the Centers for Medicare & Medicaid Services (CMS) finalized...

On January 15, the Department of Justice (DOJ) released its annual report on civil fraud recoveries for FY2024 along with a press release highlighting DOJ's civil enforcement efforts.

Despite the recent downward trend in DOJ healthcare industry settlements, the first quarter of 2024 saw many noteworthy False Claims Act (FCA) and civil healthcare fraud settlements...

On July 31, 2025, the Health Resources and Services Administration (HRSA) Office of Pharmacy Affairs (OPA) announced the availability of a voluntary 340B Rebate Model Pilot Program that will allow drug manufacturers to provide 340B-discounted drug prices using a rebate mechanism in limited cases starting January 1, 2026.

In Advisory Opinion 26-17, OIG approved a proposed arrangement in which a nonprofit, tax-exempt charitable organization would provide health insurance premium assistance and copayment assistance to patients with rare and chronic diseases, funded in part by pharmaceutical manufacturers.

The 42nd annual J.P. Morgan Healthcare Conference started with clear skies and overall optimism from investors. But with Jamie Dimon's prediction of a recession in 2024...

In this post, we summarize noteworthy False Claims Act (FCA) decisions so far from 2023.

Congress established a new Rural Health Transformation (RHT) Program earlier this year as part of the passage of budget reconciliation legislation, commonly known as the One Big Beautiful Bill Act.

Two recent announcements from the Centers for Medicare & Medicaid Services (CMS) offer early indicators as to how the Trump administration, including CMS administrator Dr. Mehmet Oz, may approach the Medicare Advantage (MA) industry over the next four years.